Advances in pharmacotherapy for the prophylactic treatment of resistant and refractory migraine
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2022.2088281
Abstract: ABSTRACT Introduction Refractory migraine is associated with low quality of life and great socioeconomic burden. Despite high need for effective, tolerable preventive therapies, there has been little research on potential therapeutic options. Monoclonal antibodies (mAbs)… read more here.
Keywords: migraine; pharmacotherapy prophylactic; refractory migraine; treatment ... See more keywords